Incretin Responses Differ by Glycemic Control in T2DM Tags hBA1c GLP-1 agonists Read more about Incretin Responses Differ by Glycemic Control in T2DM
Downstream Medication Use Differs After GLP-1 vs SGLT2 Start in T2DM Tags GLP-1 agonists SGLT-2 Inhibitor Read more about Downstream Medication Use Differs After GLP-1 vs SGLT2 Start in T2DM
Tirzepatide Shows Lower MCI Risk vs Semaglutide in T2DM Tags GLP-1 agonists Read more about Tirzepatide Shows Lower MCI Risk vs Semaglutide in T2DM
Combination Therapy Tied to Reduced Colon Cancer Risk in T2DM Tags GLP-1 agonists SGLT-2 Inhibitor Read more about Combination Therapy Tied to Reduced Colon Cancer Risk in T2DM
Early Metabolic and Liver Improvements Seen With Tirzepatide in T2DM Tags hBA1c GLP-1 agonists Read more about Early Metabolic and Liver Improvements Seen With Tirzepatide in T2DM
How Does Oral Semaglutide Perform in Real-World T2DM Care? Tags Hypoglycemia hBA1c GLP-1 agonists Read more about How Does Oral Semaglutide Perform in Real-World T2DM Care?
GLP-1-Based Therapies Show Consistent Renal Benefits in T2DM Tags GLP-1 agonists Read more about GLP-1-Based Therapies Show Consistent Renal Benefits in T2DM
Can a Degludec-Liraglutide Combo Improve HbA1c in Routine Care? Tags FBS Hypoglycemia hBA1c Long acting GLP-1 agonists Read more about Can a Degludec-Liraglutide Combo Improve HbA1c in Routine Care?
Nearly 60% Reach HbA1c Target After Starting Weekly Semaglutide Tags hBA1c GLP-1 agonists Read more about Nearly 60% Reach HbA1c Target After Starting Weekly Semaglutide
Vision-Threatening Events Not Increased With GLP-1 Agonists Tags GLP-1 agonists Read more about Vision-Threatening Events Not Increased With GLP-1 Agonists